Eli Lilly

"Eli Lilly is adding new abilities to make drugs that can reprogram cells inside the body, agreeing on Monday to acquire privately held biotechnology company Kelonia Therapeutics in a deal worth as much as $7 billion."https://www.biopharmadive.com/news/lilly-kelonia-acquire-in-vivo-cell-therapy-multiple-myeloma/817953/?utm_source=join1440&utm_medium=email&utm_placement=newsletter&user_id=66c4c92f5d78644b3ac5d5b4